TFAM and metabolic dysfunction-associated steatohepatitis: [24] reported that PGC-1α and TFAM expression were reduced, which indicated disruption of mitochondrial biogenesis in nonalcoholic steatohepatitis (NASH) and early fibrosis in mouse liver.